Overview

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Status:
RECRUITING

Trial end date:
2027-06-03

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the PK, Safety, Tolerability (all cohorts) and Efficacy (cohort 3), of once-a-month long-acting SC injection of dose escalating Cariprazine Depot in subjects eligible for treatment with oral Cariprazine.

Phase:

PHASE1

Details

Lead Sponsor:

Mapi Pharma Ltd.

Treatments:

cariprazine